Zobrazeno 1 - 2
of 2
pro vyhledávání: '"PEDRO ALEJANDRO Alejandro Lucero-Diaz"'
Autor:
Juan P Marquez-Manriquez, JOSE ANTONIO MATUTE-BRISENO, SALVADOR ICEDO-ZAMORA, ALBERTO DURAZO-ACUNA, PEDRO ALEJANDRO Alejandro Lucero-Diaz, MARTIN ORLANDO ROSAS-DELGADO, ALEJANDRO CAMACHO-HERNANDEZ
Publikováno v:
The Journal of Immunology. 202:70.17-70.17
Background Most of the immunotherapy trials in progressive cancer are limited targeting few antigens and most of them are not clinically relevant as they are not important for tumor survival. For such reason our approach is to develop multi peptide i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98dc5498f407ba24194891601faea0f2
https://doi.org/10.4049/jimmunol.202.supp.70.17
https://doi.org/10.4049/jimmunol.202.supp.70.17
Autor:
Juan P Marquez-Manriquez, JOSE ANTONIO MATUTE-BRISENO, ALEJANDRO CAMACHO-HERNANDEZ, SALVADOR ICEDO-ZAMORA, PEDRO ALEJANDRO Alejandro Lucero-Diaz
Publikováno v:
The Journal of Immunology. 202:131.17-131.17
Background Most of the ELISA studies in cancer patients use different source of antigens, which is mainly limited to recombinant proteins produced in E. coli and this may impact the global results between the studies using even the same antigen becau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f81340ec106e4478e28651db7526a15
https://doi.org/10.4049/jimmunol.202.supp.131.17
https://doi.org/10.4049/jimmunol.202.supp.131.17